Stay updated on Obeticholic Acid in NASH Clinical Trial
Sign up to get notified when there's something new on the Obeticholic Acid in NASH Clinical Trial page.

Latest updates to the Obeticholic Acid in NASH Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Study Record page now displays a 403 Forbidden error with the site header and footer, indicating access to the page is blocked rather than showing the study details.SummaryDifference16%

- Check19 days agoChange DetectedThe revision label has been updated to v3.7.0, indicating a new software update. The previous revision v3.6.6 is no longer visible in the updated history.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.6.6 was added, replacing the previous v3.6.5. This change reflects a minor update to the study record system rather than any modification to the study data or display content.SummaryDifference0.0%

- Check55 days agoChange DetectedFooter now shows Revision: v3.6.5, up from v3.6.4, indicating a minor site update. The study details and available actions on the page remain unchanged.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the prior v3.6.3, indicating a new version of the study record. This metadata update tracks page changes rather than altering trial information.SummaryDifference0.0%

- Check83 days agoChange DetectedThe glossary entry now uses Steatotic Liver Disease and Fatty Liver Disease has been removed. This updates the page to reflect current terminology for the disease category and aligns the MeSH terms used to describe the study's context.SummaryDifference0.0%

Stay in the know with updates to Obeticholic Acid in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeticholic Acid in NASH Clinical Trial page.